These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Stereotactic delivery of a recombinant adenovirus into a C6 glioma cell line in a rat brain tumor model. Badie B; Hunt K; Economou JS; Black KL Neurosurgery; 1994 Nov; 35(5):910-5; discussion 915-6. PubMed ID: 7838341 [TBL] [Abstract][Full Text] [Related]
3. Combined radiation and p53 gene therapy of malignant glioma cells. Badie B; Goh CS; Klaver J; Herweijer H; Boothman DA Cancer Gene Ther; 1999; 6(2):155-62. PubMed ID: 10195882 [TBL] [Abstract][Full Text] [Related]
4. Beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses. Puumalainen AM; Vapalahti M; Agrawal RS; Kossila M; Laukkanen J; Lehtolainen P; Viita H; Paljärvi L; Vanninen R; Ylä-Herttuala S Hum Gene Ther; 1998 Aug; 9(12):1769-74. PubMed ID: 9721087 [TBL] [Abstract][Full Text] [Related]
5. Adenovirally mediated gene transfer into experimental solid brain tumors and leptomeningeal cancer cells. Viola JJ; Ram Z; Walbridge S; Oshiro EM; Trapnell B; Tao-Cheng JH; Oldfield EH J Neurosurg; 1995 Jan; 82(1):70-6. PubMed ID: 7815137 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of adenoviral p53 delivery with SCH58500 in the intracranial 9l and RG2 models. Bowers G; He J; Schulz K; Olivarria G; Maneval D; Olson JJ Front Biosci; 2003 May; 8():a54-61. PubMed ID: 12700117 [TBL] [Abstract][Full Text] [Related]
7. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Ram Z; Culver KW; Walbridge S; Blaese RM; Oldfield EH Cancer Res; 1993 Jan; 53(1):83-8. PubMed ID: 8380127 [TBL] [Abstract][Full Text] [Related]
8. [Gene transduction for experimental brain tumors using recombinant adenovirus vector]. Ichikawa T; Tamiya T; Adachi Y; Ono Y; Matsumoto K; Furuta T; Ohmoto T; Yoshida Y; Hamada H No To Shinkei; 1998 Aug; 50(8):731-8. PubMed ID: 9757466 [TBL] [Abstract][Full Text] [Related]
9. Adenoviral vector-mediated gene transfer: timing of wild-type p53 gene expression in vivo and effect of tumor transduction on survival in a rat glioma brachytherapy model. Bampoe J; Glen J; Hubbard SL; Salhia B; Shannon P; Rutka J; Bernstein M J Neurooncol; 2000 Aug; 49(1):27-39. PubMed ID: 11131984 [TBL] [Abstract][Full Text] [Related]
10. Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma. Chang JW; Lee H; Kim E; Lee Y; Chung SS; Kim JH Neurosurgery; 2000 Oct; 47(4):931-8; discussion 938-9. PubMed ID: 11014433 [TBL] [Abstract][Full Text] [Related]
11. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo. Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990 [TBL] [Abstract][Full Text] [Related]
12. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene. Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183 [TBL] [Abstract][Full Text] [Related]
13. Potentials and limitations of adenovirus-p53 gene therapy for brain tumors. Hong YK; Joe YA; Yang YJ; Lee KS; Son BC; Jeun SS; Chung DS; Cho KK; Park CK; Kim MC; Kim HK; Yung WK; Kang JK J Korean Med Sci; 2000 Jun; 15(3):315-22. PubMed ID: 10895975 [TBL] [Abstract][Full Text] [Related]
14. In vivo adenoviral-mediated human p53 tumor suppressor gene transfer and expression in rat liver after resection. Drazan KE; Shen XD; Csete ME; Zhang WW; Roth JA; Busuttil RW; Shaked A Surgery; 1994 Aug; 116(2):197-203; discussion 203-4. PubMed ID: 8047986 [TBL] [Abstract][Full Text] [Related]
15. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase. Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394 [TBL] [Abstract][Full Text] [Related]
16. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Nakamura K; Ito Y; Kawano Y; Kurozumi K; Kobune M; Tsuda H; Bizen A; Honmou O; Niitsu Y; Hamada H Gene Ther; 2004 Jul; 11(14):1155-64. PubMed ID: 15141157 [TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated p53 gene delivery potentiates the radiation-induced growth inhibition of experimental brain tumors. Badie B; Kramar MH; Lau R; Boothman DA; Economou JS; Black KL J Neurooncol; 1998 May; 37(3):217-22. PubMed ID: 9524079 [TBL] [Abstract][Full Text] [Related]
18. Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses. Sandmair AM; Loimas S; Puranen P; Immonen A; Kossila M; Puranen M; Hurskainen H; Tyynelä K; Turunen M; Vanninen R; Lehtolainen P; Paljärvi L; Johansson R; Vapalahti M; Ylä-Herttuala S Hum Gene Ther; 2000 Nov; 11(16):2197-205. PubMed ID: 11084677 [TBL] [Abstract][Full Text] [Related]
19. Gene therapy using an adenovirus vector for apoptosis-related genes is a highly effective therapeutic modality for killing glioma cells. Shinoura N; Hamada H Curr Gene Ther; 2003 Apr; 3(2):147-53. PubMed ID: 12653407 [TBL] [Abstract][Full Text] [Related]
20. Isolated limb perfusion: a novel delivery system for wild-type p53 and fiber-modified oncolytic adenoviruses to extremity sarcoma. Hannay J; Davis JJ; Yu D; Liu J; Fang B; Pollock RE; Lev D Gene Ther; 2007 Apr; 14(8):671-81. PubMed ID: 17287860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]